What Fouad is missing is incremental production, that is increased production from the current run rate will have a cost of approximately $200 at ton. In addition as demand outside China increases, Syrah has stated they receive better pricing. Improved grade of large flake would only make the picture brighter. Syrah needs to maintain solid control of their production plan and push sales.
- Forums
- ASX - By Stock
- SYR
- Ann: Q2 Interim Update
Ann: Q2 Interim Update, page-50
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
0.025(9.26%) |
Mkt cap ! $305.2M |
Open | High | Low | Value | Volume |
28.0¢ | 30.0¢ | 28.0¢ | $1.532M | 5.275M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 184478 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 303617 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 159478 | 0.295 |
13 | 310340 | 0.290 |
12 | 835211 | 0.285 |
9 | 357220 | 0.280 |
11 | 297315 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 303617 | 12 |
0.305 | 216826 | 7 |
0.310 | 309705 | 8 |
0.315 | 83015 | 7 |
0.320 | 142084 | 5 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
NEWS
New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
SYR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online